ID: ALA4780114

Max Phase: Preclinical

Molecular Formula: C22H28N2OS

Molecular Weight: 368.55

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCc1cc2nc3ccc(N(C)C)cc3sc-2cc1=O

Standard InChI:  InChI=1S/C22H28N2OS/c1-4-5-6-7-8-9-10-16-13-19-22(15-20(16)25)26-21-14-17(24(2)3)11-12-18(21)23-19/h11-15H,4-10H2,1-3H3

Standard InChI Key:  KKRVHMNGGWPFAZ-UHFFFAOYSA-N

Associated Targets(Human)

Lymphocyte 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 368.55Molecular Weight (Monoisotopic): 368.1922AlogP: 5.73#Rotatable Bonds: 8
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.11CX LogP: 6.17CX LogD: 6.17
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.38Np Likeness Score: -0.87

References

1. Liu J,Bandyopadhyay I,Zheng L,Khdour OM,Hecht SM.  (2020)  Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease.,  11  (11): [PMID:33214825] [10.1021/acsmedchemlett.0c00293]

Source